BRD4 and Cancer: going beyond transcriptional regulation

被引：0
|
作者：
Benedetta Donati
Eugenia Lorenzini
Alessia Ciarrocchi
机构：
[1] Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia,Laboratory of Translational Research
来源：
Molecular Cancer | / 17卷
关键词：
BRD4; BET inhibitors; Transcriptional regulation; DNA damage response; Telomere regulation; Unconventional function; Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
BRD4, member of the Bromodomain and Extraterminal (BET) protein family, is largely acknowledged in cancer for its role in super-enhancers (SEs) organization and oncogenes expression regulation. Inhibition of BRD4 shortcuts the communication between SEs and target promoters with a subsequent cell-specific repression of oncogenes to which cancer cells are addicted and cell death. To date, this is the most credited mechanism of action of BET inhibitors, a class of small molecules targeting BET proteins which are currently in clinical trials in several cancer settings.
引用
收藏
相关论文
共 50 条
  • [21] BRD4 sustains p63 transcriptional program in keratinocytes
    Foffi, E.
    Violante, A.
    Pecorari, R.
    Lena, A. M.
    Rugolo, F.
    Melino, G.
    Candi, E.
    BIOLOGY DIRECT, 2024, 19 (01)
  • [22] Inhibition of BRD4 suppresses the malignancy of breast cancer cells via regulation of Snail
    Lu, Linlin
    Chen, Zhuojia
    Lin, Xinyao
    Tian, Lin
    Su, Qiao
    An, Panpan
    Li, Wuguo
    Wu, Yingmin
    Du, Jun
    Shan, Hong
    Chiang, Cheng-Ming
    Wang, Hongsheng
    CELL DEATH AND DIFFERENTIATION, 2020, 27 (01): : 255 - 268
  • [23] Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function
    Sakamaki, Jun-ichi
    Wilkinson, Simon
    Hahn, Marcel
    Tasdemir, Nilgun
    O'Prey, Jim
    Clark, William
    Hedley, Ann
    Nixon, Colin
    Long, Jaclyn S.
    New, Maria
    Van Acker, Tim
    Tooze, Sharon A.
    Lowe, Scott W.
    Dikic, Ivan
    Ryan, Kevin M.
    MOLECULAR CELL, 2017, 66 (04) : 517 - +
  • [24] Inhibition of BRD4 suppresses the malignancy of breast cancer cells via regulation of Snail
    Linlin Lu
    Zhuojia Chen
    Xinyao Lin
    Lin Tian
    Qiao Su
    Panpan An
    Wuguo Li
    Yingmin Wu
    Jun Du
    Hong Shan
    Cheng-Ming Chiang
    Hongsheng Wang
    Cell Death & Differentiation, 2020, 27 : 255 - 268
  • [25] BRD4 degradation by PROTACs represents a more effective therapeutic strategy than BRD4 inhibitors in ovarian cancer
    Raina, Kanak
    Lu, Jing
    Qian, Yimin
    Altieri, Martha
    Dong, Hanging
    Wang, Jing
    Chen, Xin
    Crew, Andrew
    Coleman, Kevin
    Crews, Craig
    Winkler, James
    CANCER RESEARCH, 2016, 76
  • [26] Opposing Functions of BRD4 Isoforms in Breast Cancer
    Wu, Shwu-Yuan
    Lee, Chien-Fei
    Lai, Hsien-Tsung
    Yu, Cheng-Tai
    Lee, Ji-Eun
    Zuo, Hao
    Tsai, Sophia Y.
    Tsai, Ming-Jer
    Ge, Kai
    Wan, Yihong
    Chiang, Cheng-Ming
    MOLECULAR CELL, 2020, 78 (06) : 1114 - +
  • [27] Regulation of Aurora B Expression by the Bromodomain Protein Brd4
    You, Jianxin
    Li, Qing
    Wu, Chong
    Kim, Jina
    Ottinger, Matthias
    Howley, Peter M.
    MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (18) : 5094 - 5103
  • [28] Targeting Brd4 for cancer therapy: inhibitors and degraders
    Duan, Yingchao
    Guan, Yuanyuan
    Qin, Wenping
    Zhai, Xiaoyu
    Yu, Bin
    Liu, Hongmin
    MEDCHEMCOMM, 2018, 9 (11) : 1779 - 1802
  • [29] Dual HDAC/BRD4 inhibitors against cancer
    Omidkhah, Negar
    Hadizadeh, Farzin
    Ghodsi, Razieh
    MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (10) : 1822 - 1836
  • [30] Brd4 and JMJD6-Associated Anti-Pause Enhancers in Regulation of Transcriptional Pause Release
    Liu, Wen
    Ma, Qi
    Wong, Kaki
    Li, Wenbo
    Ohgi, Kenny
    Zhang, Jie
    Aggarwal, Aneel K.
    Rosenfeld, Michael G.
    CELL, 2013, 155 (07) : 1581 - 1595
12345